Cargando…

Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy

The synucleinopathy underlying multiple system atrophy (MSA) is characterized by the presence of abundant amyloid inclusions containing fibrillar α-synuclein (α-syn) aggregates in the brains of the patients and is associated with an extensive neurodegeneration. In contrast to Parkinson’s disease (PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Laferrière, Florent, He, Xin, Zinghirino, Federica, Doudnikoff, Evelyne, Faggiani, Emilie, Meissner, Wassilios G., Bezard, Erwan, De Giorgi, Francesca, Ichas, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693764/
https://www.ncbi.nlm.nih.gov/pubmed/33138150
http://dx.doi.org/10.3390/cells9112371
_version_ 1783614820590813184
author Laferrière, Florent
He, Xin
Zinghirino, Federica
Doudnikoff, Evelyne
Faggiani, Emilie
Meissner, Wassilios G.
Bezard, Erwan
De Giorgi, Francesca
Ichas, François
author_facet Laferrière, Florent
He, Xin
Zinghirino, Federica
Doudnikoff, Evelyne
Faggiani, Emilie
Meissner, Wassilios G.
Bezard, Erwan
De Giorgi, Francesca
Ichas, François
author_sort Laferrière, Florent
collection PubMed
description The synucleinopathy underlying multiple system atrophy (MSA) is characterized by the presence of abundant amyloid inclusions containing fibrillar α-synuclein (α-syn) aggregates in the brains of the patients and is associated with an extensive neurodegeneration. In contrast to Parkinson’s disease (PD) where the pathological α-syn aggregates are almost exclusively neuronal, the α-syn inclusions in MSA are principally observed in oligodendrocytes (OLs) where they form glial cytoplasmic inclusions (GCIs). This is intriguing because differentiated OLs express low levels of α-syn, yet pathogenic amyloid α-syn seeds require significant amounts of α-syn monomers to feed their fibrillar growth and to eventually cause the buildup of cytopathological inclusions. One of the transgenic mouse models of this disease is based on the targeted overexpression of human α-syn in OLs using the PLP promoter. In these mice, the histopathological images showing a rapid emergence of S129-phosphorylated α-syn inside OLs are considered as equivalent to GCIs. Instead, we report here that they correspond to the accumulation of phosphorylated α-syn monomers/oligomers and not to the appearance of the distinctive fibrillar α-syn aggregates that are present in the brains of MSA or PD patients. In spite of a propensity to co-sediment with myelin sheath contaminants, the phosphorylated forms found in the brains of the transgenic animals are soluble (>80%). In clear contrast, the phosphorylated species present in the brains of MSA and PD patients are insoluble fibrils (>95%). Using primary cultures of OLs from PLP-αSyn mice we observed a variable association of S129-phosphorylated α-syn with the cytoplasmic compartment, the nucleus and with membrane domains suggesting that OLs functionally accommodate the phospho-α-syn deriving from experimental overexpression. Yet and while not taking place spontaneously, fibrillization can be seeded in these primary cultures by challenging the OLs with α-syn preformed fibrils (PFFs). This indicates that a targeted overexpression of α-syn does not model GCIs in mice but that it can provide a basis for seeding aggregation using PFFs. This approach could help establishing a link between α-syn aggregation and the development of a clinical phenotype in these transgenic animals.
format Online
Article
Text
id pubmed-7693764
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76937642020-11-28 Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy Laferrière, Florent He, Xin Zinghirino, Federica Doudnikoff, Evelyne Faggiani, Emilie Meissner, Wassilios G. Bezard, Erwan De Giorgi, Francesca Ichas, François Cells Article The synucleinopathy underlying multiple system atrophy (MSA) is characterized by the presence of abundant amyloid inclusions containing fibrillar α-synuclein (α-syn) aggregates in the brains of the patients and is associated with an extensive neurodegeneration. In contrast to Parkinson’s disease (PD) where the pathological α-syn aggregates are almost exclusively neuronal, the α-syn inclusions in MSA are principally observed in oligodendrocytes (OLs) where they form glial cytoplasmic inclusions (GCIs). This is intriguing because differentiated OLs express low levels of α-syn, yet pathogenic amyloid α-syn seeds require significant amounts of α-syn monomers to feed their fibrillar growth and to eventually cause the buildup of cytopathological inclusions. One of the transgenic mouse models of this disease is based on the targeted overexpression of human α-syn in OLs using the PLP promoter. In these mice, the histopathological images showing a rapid emergence of S129-phosphorylated α-syn inside OLs are considered as equivalent to GCIs. Instead, we report here that they correspond to the accumulation of phosphorylated α-syn monomers/oligomers and not to the appearance of the distinctive fibrillar α-syn aggregates that are present in the brains of MSA or PD patients. In spite of a propensity to co-sediment with myelin sheath contaminants, the phosphorylated forms found in the brains of the transgenic animals are soluble (>80%). In clear contrast, the phosphorylated species present in the brains of MSA and PD patients are insoluble fibrils (>95%). Using primary cultures of OLs from PLP-αSyn mice we observed a variable association of S129-phosphorylated α-syn with the cytoplasmic compartment, the nucleus and with membrane domains suggesting that OLs functionally accommodate the phospho-α-syn deriving from experimental overexpression. Yet and while not taking place spontaneously, fibrillization can be seeded in these primary cultures by challenging the OLs with α-syn preformed fibrils (PFFs). This indicates that a targeted overexpression of α-syn does not model GCIs in mice but that it can provide a basis for seeding aggregation using PFFs. This approach could help establishing a link between α-syn aggregation and the development of a clinical phenotype in these transgenic animals. MDPI 2020-10-29 /pmc/articles/PMC7693764/ /pubmed/33138150 http://dx.doi.org/10.3390/cells9112371 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Laferrière, Florent
He, Xin
Zinghirino, Federica
Doudnikoff, Evelyne
Faggiani, Emilie
Meissner, Wassilios G.
Bezard, Erwan
De Giorgi, Francesca
Ichas, François
Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy
title Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy
title_full Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy
title_fullStr Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy
title_full_unstemmed Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy
title_short Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy
title_sort overexpression of α-synuclein by oligodendrocytes in transgenic mice does not recapitulate the fibrillar aggregation seen in multiple system atrophy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693764/
https://www.ncbi.nlm.nih.gov/pubmed/33138150
http://dx.doi.org/10.3390/cells9112371
work_keys_str_mv AT laferriereflorent overexpressionofasynucleinbyoligodendrocytesintransgenicmicedoesnotrecapitulatethefibrillaraggregationseeninmultiplesystematrophy
AT hexin overexpressionofasynucleinbyoligodendrocytesintransgenicmicedoesnotrecapitulatethefibrillaraggregationseeninmultiplesystematrophy
AT zinghirinofederica overexpressionofasynucleinbyoligodendrocytesintransgenicmicedoesnotrecapitulatethefibrillaraggregationseeninmultiplesystematrophy
AT doudnikoffevelyne overexpressionofasynucleinbyoligodendrocytesintransgenicmicedoesnotrecapitulatethefibrillaraggregationseeninmultiplesystematrophy
AT faggianiemilie overexpressionofasynucleinbyoligodendrocytesintransgenicmicedoesnotrecapitulatethefibrillaraggregationseeninmultiplesystematrophy
AT meissnerwassiliosg overexpressionofasynucleinbyoligodendrocytesintransgenicmicedoesnotrecapitulatethefibrillaraggregationseeninmultiplesystematrophy
AT bezarderwan overexpressionofasynucleinbyoligodendrocytesintransgenicmicedoesnotrecapitulatethefibrillaraggregationseeninmultiplesystematrophy
AT degiorgifrancesca overexpressionofasynucleinbyoligodendrocytesintransgenicmicedoesnotrecapitulatethefibrillaraggregationseeninmultiplesystematrophy
AT ichasfrancois overexpressionofasynucleinbyoligodendrocytesintransgenicmicedoesnotrecapitulatethefibrillaraggregationseeninmultiplesystematrophy